Deliver Your News to the World

SmallCapNewsRelease: (OTC: KKUR) Signs $25 million LOI Merger Agreement


(SmallCapNewsRelease, April 15,2010) – Jericho, N.Y. – ChromoCure Inc. announced today that it has signed a Letter of Intent with Genome Research Group (GRG). Under the terms of the Agreement, ChromoCure will acquire and merge with GRG and combine the Company’s operations and assets with all GRG Intellectual Property (IP) assets and operations.

The merger transaction is valued in excess of $25,000,000 and results in significant increases to shareholder equity and reductions in long-term liabilities. GRG management will assume control of the new entity. All current members of the ChromoCure Board and executive management will step down as part of the transaction. The Company intends to change its name to Genome Research Group to properly reflect its new operations. The ChromoCure brand will continue to be used to promote the Company’s collaborative research initiatives.

For full news release go to

SmallCapNewsRelease Gainers are Intel Corp. (NASDAQ: INTC), Logic Devices Inc. (NASDAQ:
LOGC), Akorn Inc. (NASDAQ: AKRX), K-v Pharmaceutical Co. (NYSE: KV.A), Apple Inc. (NASDAQ: AAPL), Dell Inc. (NASDAQ: DELL), Oracle Corp. (NASDAQ: ORCL), and Microsoft Corp. (NASDAQ: MSFT).

SmallCapNewsRelease Decliners are WebMD Health Corp (Nasdaq: WBMD), ICU Medical Inc. (Nasdaq: ICUI), Intuitive Surgical, Inc. (Nasdaq: ISRG), Zoran, Corp. (Nasdaq: ZRAN), Albany Molecular Research (Nasdaq: AMRI), NIC, Inc. (Nasdaq: EGOV), and Nighthawk Radiology Holdings, Inc. (Nasdaq: NHWK).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Small Cap News Release twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send no faxes or emails.


 cancer detection
 hot stock pick

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.